JNIS_BMJ Profile Banner
JNIS Profile
JNIS

@JNIS_BMJ

Followers
11K
Following
126
Media
3K
Statuses
4K

The Journal of NeuroInterventional Surgery aims to be the leading peer review journal for the field of neurointerventional surgery.

Joined May 2010
Don't wanna be here? Send us removal request.
@JNIS_BMJ
JNIS
1 hour
Editor's Column on the newly published CREST 2 study: https://t.co/cNjioOIzwT. Our editors conclude: CREST-2 demonstrates that percutaneous carotid stenting, when performed with rigorous training and careful anatomical selection, must be included as a primary option in shared
Tweet card summary image
jnis.bmj.com
Management of asymptomatic high-grade carotid stenosis has remained a matter of debate as advances in best medical therapy and revascularization techniques have challenged the relevance of earlier...
0
1
0
@JNIS_BMJ
JNIS
9 days
🚀 New meta-analysis: Mechanical thrombectomy for cervical artery dissection (CeAD) strokes is safe, effective, and linked to better 90-day outcomes and lower mortality than other LVO causes. 👉 https://t.co/DR3mcXxb29 #NeuroIR #Stroke #Thrombectomy
1
13
27
@JNIS_BMJ
JNIS
11 days
Technical video shows AI overlay visualization boosting distal branch penetration and safety during cSDH treatment. Would you consider using AI support for #mmaembo ? Check it out → https://t.co/YHcgFucjj6 #subduralhematoma #neurointervention @CeoImed
0
1
17
@JNIS_BMJ
JNIS
11 days
ARISE II Consortium meets to develop recommendations to drive future research and management for #ICH - faster intervention, AI, mobile stroke units, and new surgical strategies.đź§  https://t.co/cYmKU7b326 @aKashkoushMD @bainmd @AdamArthurMD @JMoccoMD @JanKarlBurkhar1
0
5
34
@JNIS_BMJ
JNIS
20 days
Pericarotid fat texture on CTA boosted in-stent restenosis prediction (AUC 0.88 vs 0.66–0.84) beyond clinical + imaging factors. Perivascular inflammation may be the missing biomarker. #NeuroIR #CarotidStent #AI #Radiomicshttps://bit.ly/4qU9xJx
0
4
10
@JNIS_BMJ
JNIS
21 days
Innovative pain control after aSAH: Intra-MMA lidocaine (± dexamethasone) during embolization cut pain scores up to 75% and slashed opioid use—with no complications. Targeted dural therapy shows promise. #NeuroIR #subarachnoidhemorrhage #PainManagement #MMAembo
1
17
36
@JNIS_BMJ
JNIS
21 days
First look at a novel neurointerventional brain-sparing endovascular approach to aqueductal stenosis: accessing the 4th ventricle via the foramen magnum to stent or dilate the aqueduct without parenchymal violation in cadaveric models. https://t.co/pLzwJqrc01 #NeuroIR
2
17
50
@JNIS_BMJ
JNIS
22 days
Prasugrel monotherapy was non-inferior to DAPT for distal aneurysm flow diversion with the p48 MW HPC—no increase in stroke or deficits at 30 days. Results from the DART trial #NeuroIR #FlowDiverter #Stroke #Endovascular https://t.co/EFEMfoRdGq
1
10
19
@JNIS_BMJ
JNIS
23 days
In 21 years of DAVF data, pseudophlebitic pattern (PPP) appeared in ~23% of cases—linked to worse outcomes before adjustment, but not an independent prognostic marker after matching. https://t.co/ReK5DAmgfG #NeuroIR #DAVF #Endovascular
1
5
16
@JNIS_BMJ
JNIS
23 days
New #flowdiverter coating tech: In a rabbit model, P8RI-coated Silk Vista showed faster and more complete neointimal coverage than bare Silk Vista or Pipeline Vantage by day 28—suggesting accelerated arterial healing. https://t.co/SEANbvY8bU #NeuroIR #FlowDiverter #Endovascular
0
5
14
@JNIS_BMJ
JNIS
23 days
Results of ANGEL-TNK: IA tenecteplase after thrombectomy improved 90-day outcomes only in ICA occlusions—not MCA M1/M2—and cut hemorrhage risk nearly 60%. https://t.co/gOSHaASCBG #Stroke #NeuroIR #LVO #Tenecteplase #Thrombectomy
1
8
28
@JNIS_BMJ
JNIS
25 days
64% of neurointerventionalists report PTSD-level stress after major complications—often long-lasting and worsened by lack of institutional support. The “second victim” is real. https://t.co/XjJbVnNRuB #NeuroIR #PhysicianWellness #MedTwitter
0
7
26
@JNIS_BMJ
JNIS
25 days
In ICH, rising neutrophil-to-lymphocyte ratio predicts mortality — unless the hematoma’s evacuated with SCUBA method. Minimally invasive removal may blunt inflammation-driven injury. #Stroke #ICH https://t.co/p0mf3H7GkF
0
3
3
@JNIS_BMJ
JNIS
28 days
Exciting breakthrough in #Neurointervention! In rabbits, rosuvastatin boosted healing after flow diverter placement—better aneurysm closure, open side branches, and stronger vessel lining. A hint at smarter stent therapy ahead. @fdianamd #NeuroIntervention #flowdiversion
1
9
24
@JNIS_BMJ
JNIS
28 days
Is endovascular therapy the future of brain tumor treatment? Emerging research on Yttrium-90 endovascular radiosurgery hints at a way to target tumors from within—crossing the BBB and sparing healthy tissue. Early signs point to this being a game-changing therapy! #NeuroOncology
4
22
75
@JNIS_BMJ
JNIS
2 months
'CAR T-cell therapy and neurology' BMJ Neurology Open has calls for papers in your subject area. Discover the topic collection: https://t.co/ojZ12lZYwe
1
0
1
@JNIS_BMJ
JNIS
2 months
⏰ Time for some basic science! The study demonstrates that a novel eccentric carotid stenosis model can be created using cryoinjury. Link: https://t.co/QdDyncxvRI
0
3
13
@JNIS_BMJ
JNIS
2 months
A new study shows delayed recanalization of brain arteriovenous malformation after complete obliteration by endovascular embolization. Residual hematoma and vein- and artery- cast mismatch is predictive of recurrence! https://t.co/MBc5Iw3jfh
1
3
14
@JNIS_BMJ
JNIS
2 months
🧠 Should you embolize AVMs associated with aneurysms? New article: https://t.co/aFsNL1vxCu The ruptured subgroup seems to show the most benefit in this cohort of the MATCH registry, with 64 matched pairs. 🩸
0
12
18
@JNIS_BMJ
JNIS
2 months
We all know that ⏰ is 🧠. Do different time intervals have different impacts on outcomes? This large retrospective study demonstrates that procedure duration predicts outcomes more than prehospital delay for EVTs! This emphasizes the importance of skilled interventionalists
2
17
29